Key highlights
Explore more statements
Filter
Topics
Period
Filter by
recent search
Showing: 1 – 04 of 4 Media Statements
![Statement document icon Statement document icon](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/doc.png)
22 June 2023
Ipsen CEO David Loew is elected to EFPIA leadership; joins industry partners to warn of impact of EU pharma legislation
On Wednesday 21 June, David Loew was elected second Vice President of the European Federation of Pharmaceutical Industries and Associations (EFPIA). Yesterday’s appointments also included Lars Fruergaard Jørgensen, Chief Executive of Novo Nordisk, as EFPIA President, and Stefan Oelrich, Head…
![Statement document icon Statement document icon](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/doc.png)
06 June 2023
![Statement document icon Statement document icon](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/doc.png)
24 April 2023
Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges
Ipsen is committed to bringing innovative medicines to the rare disease community where a significant unmet need exists and innovation in treatments is lacking.
![Statement document icon Statement document icon](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/doc.png)
20 February 2023
Offering support to those impacted in Turkey & Syria
We are deeply saddened by the tragic earthquake across Turkey and Syria and the worsening humanitarian crisis. Our thoughts are with all of those impacted by the devastating events and our gratitude to those who are bravely leading the rescue…